• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.

作者信息

Easty D J, Guthrie B A, Maung K, Farr C J, Lindberg R A, Toso R J, Herlyn M, Bennett D C

机构信息

St. George's Hospital Medical School, London, United Kingdom.

出版信息

Cancer Res. 1995 Jun 15;55(12):2528-32.

PMID:7780963
Abstract

Epithelial cell kinase (ECK) is a receptor protein tyrosine kinase, the role of which in melanoma biology is unclear. Here we studied the role of ECK during melanoma progression. ECK mRNA was overexpressed in virtually all melanoma lines tested, and levels were significantly higher in cell lines from distant metastases than primary melanomas; melanocytes were negative. Gene amplification was not detected in melanomas. Levels of ECK protein corresponded well with mRNA levels. B61 or LERK-1, recently identified as an ECK ligand, stimulated the growth of ECK-expressing melanoma cell lines, its first identified biological activity. Melanoma chemotaxis and chemoinvasion were not affected by B61. Growth of normal melanocytes was not affected. mRNA for B61 was detected in both melanoma cell lines and normal melanocytes. B61 was also identified by Western blotting and ECK binding activity with the use of a BIAcore binding assay in melanoma cell-conditioned media. These results suggest that B61 is an autocrine growth factor for melanomas but not normal melanocytes.

摘要

相似文献

1
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Cancer Res. 1995 Jun 15;55(12):2528-32.
2
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.Lerk-5/Eplg5信使核糖核酸的过表达:人类恶性黑色素瘤中肿瘤发生性增加和转移潜能增强的一种新标志物。
Clin Cancer Res. 1998 Mar;4(3):791-7.
3
B61 is a ligand for the ECK receptor protein-tyrosine kinase.
Nature. 1994 Apr 7;368(6471):558-60. doi: 10.1038/368558a0.
4
Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function.上皮细胞激酶 - B61:一种调节肠道上皮迁移和屏障功能的自分泌环。
Am J Physiol. 1997 Oct;273(4):G824-32. doi: 10.1152/ajpgi.1997.273.4.G824.
5
Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.黑色素瘤生长刺激活性(MGSA)在正常黑素细胞、痣细胞和恶性黑素细胞生长中的作用表征。
J Cell Biochem. 1990 Dec;44(4):207-19. doi: 10.1002/jcb.240440403.
6
Up-regulation of ephrin-A1 during melanoma progression.黑色素瘤进展过程中 Ephrin-A1 的上调。
Int J Cancer. 1999 Oct 22;84(5):494-501. doi: 10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o.
7
Desensitization of melanoma cells to autocrine TGF-beta isoforms.黑色素瘤细胞对自分泌转化生长因子-β 亚型的脱敏作用。
J Cell Physiol. 1999 Feb;178(2):179-87. doi: 10.1002/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5.
8
Molecular cloning and expression of rat and mouse B61 gene: implications on organogenesis.
Oncogene. 1995 Sep 7;11(5):879-83.
9
Expression patterns of S100 proteins in melanocytes and melanocytic lesions.S100蛋白在黑素细胞及黑素细胞性病变中的表达模式
Melanoma Res. 2009 Aug;19(4):215-25. doi: 10.1097/CMR.0b013e32832c6358.
10
Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.不同转移能力的人黑色素瘤细胞系中受体酪氨酸激酶表达的肿瘤内异质性。
Anticancer Res. 1994 Sep-Oct;14(5A):1759-65.

引用本文的文献

1
Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort.一项针对大型肿瘤队列的RNA和DNA外显子组联合检测的临床及分析验证
Commun Med (Lond). 2025 Jun 16;5(1):236. doi: 10.1038/s43856-025-00934-3.
2
New findings about halogenated boroxine cytotoxicity and deregulation of cell death-related genes in GR-M melanoma cells.新发现的卤代硼氧烷细胞毒性及其对 GR-M 黑素瘤细胞细胞死亡相关基因的调控作用。
Arh Hig Rada Toksikol. 2023 Apr 4;74(1):16-21. doi: 10.2478/aiht-2023-74-3702. Print 2023 Mar 1.
3
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
EphA2 和 Wee1 靶向治疗联合用于子宫内膜癌。
Int J Mol Sci. 2023 Feb 15;24(4):3915. doi: 10.3390/ijms24043915.
4
Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.非规范 EphA2 激活是前列腺癌中 PTEN 介导的转移迁移和不良临床结局的基础。
Br J Cancer. 2022 Oct;127(7):1254-1262. doi: 10.1038/s41416-022-01914-3. Epub 2022 Jul 22.
5
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity.放疗会暂时降低癌细胞对淋巴细胞细胞毒性的敏感性。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2111900119.
6
Oncogenic functions and therapeutic targeting of EphA2 in cancer.EphA2 在癌症中的致癌功能和治疗靶点。
Oncogene. 2021 Apr;40(14):2483-2495. doi: 10.1038/s41388-021-01714-8. Epub 2021 Mar 8.
7
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors.在晚期实体瘤患者中进行的 afucosylated、人源化抗-EPHA2 抗体 DS-8895a 的安全性、耐受性、药代动力学和药效学的首次人体 I 期剂量递增和扩展研究。
J Immunother Cancer. 2019 Aug 14;7(1):219. doi: 10.1186/s40425-019-0679-9.
8
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.EphA2表达是结直肠癌迁移和侵袭的关键驱动因素及不良预后标志物。
Clin Cancer Res. 2016 Jan 1;22(1):230-242. doi: 10.1158/1078-0432.CCR-15-0603. Epub 2015 Aug 17.
9
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.EPHA2是维莫非尼耐药的一个介导因子,也是黑色素瘤中一个新的治疗靶点。
Cancer Discov. 2015 Mar;5(3):274-87. doi: 10.1158/2159-8290.CD-14-0295. Epub 2014 Dec 26.
10
A role for epha2 in cell migration and refractive organization of the ocular lens.Epha2 在细胞迁移和眼球晶状体屈光组织中的作用。
Invest Ophthalmol Vis Sci. 2012 Feb 1;53(2):551-9. doi: 10.1167/iovs.11-8568.